Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06100289 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Name: A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — clinical trial record (NCT06100289)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorTakeda

Started2025-01-22

View on ClinicalTrials.gov ↗

The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for up to 34 weeks. During the study, participants will visit their study clinic several times.

Amendment history 3 changes detected by DataLookout

2026-08-04

Primary completion pushed: 2027-11-15 → 2028-05-16

2026-08-04

Completion pushed: 2027-11-15 → 2028-05-16

2026-05-16

Trial sites reduced: 57 → 54 locations

Trial Details

NCT Number	NCT06100289
Lead Sponsor	Takeda
Conditions	Ulcerative Colitis, Crohn's Disease
Enrollment	70 participants
Start Date	2025-01-22
Primary Completion	2028-05-16 (estimated)
Study Completion	2028-05-16 (estimated)
Updated on ClinicalTrials.gov	2026-08-03